ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
3,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
4,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
6,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
7,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
8,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9,1,Abortion incomplete,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
9,2,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
10,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
10,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
14,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
18,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
18,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
18,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
19,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
20,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
20,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
22,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
23,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
23,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
26,2,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
27,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
28,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
30,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
31,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
33,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,1,Headache,Headaches NEC,Headaches,Nerv,N
36,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
36,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
38,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
38,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
38,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
39,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,2,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
39,3,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
39,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
40,1,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
40,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
41,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
42,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
43,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
44,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
45,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
45,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
45,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
45,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
47,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
47,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
47,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
47,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
47,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
47,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
49,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
50,2,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
52,2,Blood gonadotrophin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
52,3,Oestradiol decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
53,1,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
54,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
55,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
57,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
58,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
60,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
61,1,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
62,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
62,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
63,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
65,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
66,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
66,2,Micrognathia,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
67,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
68,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
70,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
71,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
72,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
73,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
74,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
75,1,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
75,2,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
76,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
77,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
77,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
78,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
80,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Headache,Headaches NEC,Headaches,Nerv,N
81,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
82,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
83,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
84,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
85,1,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
86,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
86,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
87,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
87,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
87,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
87,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
88,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
89,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
91,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
92,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
92,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
92,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
92,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,8,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
93,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
94,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
94,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
95,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
96,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
96,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
98,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
99,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
100,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
101,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
101,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
101,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
102,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
102,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
103,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
103,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
104,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
104,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
106,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
106,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
107,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
107,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
110,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
111,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
112,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
113,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
114,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
114,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
115,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
117,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
117,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
117,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
118,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
119,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
119,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
119,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
121,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
123,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
123,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
123,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
123,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
123,5,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
123,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
123,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
123,8,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
123,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
123,10,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
123,11,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
124,2,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
125,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
125,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,3,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
125,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
126,2,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
127,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
128,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
128,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,3,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,4,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
128,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
128,6,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
129,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
129,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
129,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
129,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
129,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
129,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
130,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
130,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
131,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
131,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
132,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
132,2,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
132,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
133,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
133,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
133,3,Neonatal disorder,Newborn complications NEC,Neonatal and perinatal conditions,Preg,N
133,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
134,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
134,2,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
134,3,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,4,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
135,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
135,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
135,3,Foetal alcohol syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
135,4,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
135,5,Optic nerve hypoplasia,Optic nerve and optic disc disorders congenital,Eye disorders congenital,Cong,N
135,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
136,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
136,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
136,3,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,4,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
136,5,Optic nerve hypoplasia,Optic nerve and optic disc disorders congenital,Eye disorders congenital,Cong,N
136,6,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
136,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
137,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
139,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
140,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
140,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
140,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
141,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Blood follicle stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
142,2,Blood luteinising hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
142,3,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
142,4,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
142,5,Penile size reduced,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
142,6,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
143,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
143,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
143,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
143,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
143,5,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
143,6,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
143,7,Ventricular failure,Heart failures NEC,Heart failures,Card,N
143,8,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
144,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
144,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
144,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
146,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
146,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
146,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
146,4,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
147,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
148,1,Necrolytic migratory erythema,Erythemas,Epidermal and dermal conditions,Skin,N
149,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
150,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
150,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
150,3,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
150,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
152,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
153,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
154,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
154,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
154,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
154,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
154,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
154,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
154,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
154,8,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
154,9,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
154,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
154,11,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
154,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
154,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
154,14,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
154,15,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
154,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
154,17,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
154,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
154,20,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
155,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
155,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
155,4,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
155,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
155,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
155,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
155,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
155,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
155,10,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
155,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
155,12,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
155,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
155,15,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
156,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
157,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Necrolytic migratory erythema,Erythemas,Epidermal and dermal conditions,Skin,N
159,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
159,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
160,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
160,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
160,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
160,4,Headache,Headaches NEC,Headaches,Nerv,N
160,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
161,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
161,2,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
161,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
162,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
162,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
163,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
164,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
164,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
164,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
164,8,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
164,9,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
165,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
167,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
169,1,Congenital diaphragmatic anomaly,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
169,2,Pulmonary malformation,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
169,3,Septum pellucidum agenesis,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
170,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
170,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
171,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
171,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
171,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
172,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
172,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
173,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
173,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
174,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
174,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
174,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
175,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
175,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
175,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
175,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
176,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
176,2,Headache,Headaches NEC,Headaches,Nerv,N
176,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
176,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
177,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
177,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
177,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
177,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
177,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
178,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
178,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
179,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
179,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
179,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
179,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
180,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
180,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
180,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
180,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
180,5,Terminal insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
180,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,7,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
181,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
181,2,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
181,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
182,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
182,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
182,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
183,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
183,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
184,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
184,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
185,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
185,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,2,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
186,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
187,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
187,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
187,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
187,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
188,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
188,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
189,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
189,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,3,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
189,4,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
189,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
189,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
190,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
190,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
190,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
190,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
191,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
191,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
192,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
192,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,3,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
192,4,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
192,5,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
192,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
192,7,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
192,8,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
193,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
193,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
193,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
193,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
194,1,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
194,2,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
194,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
194,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
195,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,2,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
195,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
195,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
196,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
196,2,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
196,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
196,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
197,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,2,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
197,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
197,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
198,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
198,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
198,3,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,4,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
199,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
199,2,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
199,3,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
199,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
199,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
200,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
200,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
201,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
201,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
202,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
203,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
204,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
205,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
205,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
206,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
207,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
208,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
209,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
210,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
211,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
212,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
213,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
214,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
215,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
216,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
217,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
217,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
218,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
219,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
220,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
221,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
222,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
223,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
224,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
225,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
226,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
227,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
228,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
229,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
230,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
231,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
232,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
232,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
233,1,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
233,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
233,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
234,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
234,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
234,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
235,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
236,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
237,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
237,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
238,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
238,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
238,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,3,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
240,1,Choroidal coloboma,Iris and choroid disorders congenital,Eye disorders congenital,Cong,N
240,2,Iris coloboma,Iris and choroid disorders congenital,Eye disorders congenital,Cong,N
240,3,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
241,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
242,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
242,2,Electrocardiogram ST segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
242,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
242,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
243,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
243,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
243,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
243,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
243,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
243,6,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
243,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,8,Urine amphetamine positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
244,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
245,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
246,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
246,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
247,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
247,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
248,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
248,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
249,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
249,2,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
249,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
250,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
250,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
250,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
251,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
251,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
251,3,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
251,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
252,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
259,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
263,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
264,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
265,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
265,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
266,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
268,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
275,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
277,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
278,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
279,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
279,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
279,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
279,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
279,5,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
279,6,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
279,7,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
280,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
281,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
281,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
281,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
281,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
282,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
283,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
283,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
283,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
285,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
286,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
286,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
287,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
287,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
287,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
287,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
288,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
288,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
288,4,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
288,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
288,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
289,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
289,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
290,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
291,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Adhesion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
292,2,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
292,3,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
292,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
292,5,Cardiac fibroma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
292,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
292,7,Granuloma,Inflammations,General system disorders NEC,Genrl,N
292,8,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
292,9,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
292,10,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
292,11,Inflammation,Inflammations,General system disorders NEC,Genrl,N
292,12,Nephrosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
292,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
292,14,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
292,15,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
292,16,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
292,17,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
292,18,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,19,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
292,20,Spleen congestion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
292,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
293,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,2,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
294,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
294,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
294,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
295,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
297,3,Optic nerve hypoplasia,Optic nerve and optic disc disorders congenital,Eye disorders congenital,Cong,N
297,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
298,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
298,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
298,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
298,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
299,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
299,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
299,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
299,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
300,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
300,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
300,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
300,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
301,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
301,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
301,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
301,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
302,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
302,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
302,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
302,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
303,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
303,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
303,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
303,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
304,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
304,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
304,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
304,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
304,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
305,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
305,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
305,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
305,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
306,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
306,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
306,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
306,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
307,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
307,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
307,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
308,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
308,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
308,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
308,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
309,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
309,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
309,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
310,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
310,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
310,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
310,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
311,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
311,2,Signet-ring cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
311,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
312,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
312,2,Motor developmental delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
312,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
312,4,Optic nerve hypoplasia,Optic nerve and optic disc disorders congenital,Eye disorders congenital,Cong,N
312,5,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
312,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
313,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
313,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
313,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
313,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
314,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
315,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
315,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
315,4,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
315,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
315,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
315,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
315,8,Headache,Headaches NEC,Headaches,Nerv,N
315,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
315,10,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
315,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
315,12,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
315,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
315,15,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
315,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
315,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
315,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
315,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
315,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,21,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
316,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
316,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
316,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
316,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
316,5,Ischaemic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
316,6,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
316,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
316,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
316,9,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
316,10,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
317,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
317,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
317,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
317,4,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
317,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
318,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
318,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
318,3,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
318,4,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
319,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
319,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
319,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
320,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
321,1,Acute hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
321,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
321,3,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
322,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
322,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
322,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
322,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
322,5,Opiates positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
322,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
322,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
323,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
323,3,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
324,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
324,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
325,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
325,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
325,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
325,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
325,5,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
325,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
325,7,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
326,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
327,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
327,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
327,3,Victim of child abuse,Crime victims,Legal issues,SocCi,N
328,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
329,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
329,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
329,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
329,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
329,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
330,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
330,2,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
331,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
331,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
331,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
331,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
331,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
331,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
331,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,8,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
331,9,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
331,10,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,11,Thirst decreased,Feelings and sensations NEC,General system disorders NEC,Genrl,N
332,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
332,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
333,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
333,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
334,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
334,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
334,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
334,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
335,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
335,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
336,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
336,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
337,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
337,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
338,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
339,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
340,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
340,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
341,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
341,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
341,3,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
341,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
341,5,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
341,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
342,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
343,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
343,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
343,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
343,4,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
343,5,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
343,6,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
343,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
343,8,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
343,9,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
343,10,Headache,Headaches NEC,Headaches,Nerv,N
343,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
343,12,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
343,13,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
343,14,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
343,15,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
343,16,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
343,17,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
343,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,19,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
344,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
345,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
346,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
347,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
347,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
348,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
350,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
350,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
350,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
351,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
351,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
351,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
351,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
352,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
352,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
353,1,Poisoning deliberate,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
353,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
353,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
354,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
354,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
354,3,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
355,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
355,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
355,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
355,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
355,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
355,6,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
355,7,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
356,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
356,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
357,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
357,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
357,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
358,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
358,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
358,3,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
358,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
358,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
358,6,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
359,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
359,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
359,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
361,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
362,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
362,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
362,3,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
362,4,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
362,5,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
362,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
362,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
362,8,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
362,9,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
362,10,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
362,11,Headache,Headaches NEC,Headaches,Nerv,N
362,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
362,13,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
362,14,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
362,15,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
362,16,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
362,17,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
362,18,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
362,19,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
362,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
362,21,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
362,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
362,23,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
363,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
363,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
363,3,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
363,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
364,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,1,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
366,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
366,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
366,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
367,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
367,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
367,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
368,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
369,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
369,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
370,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
372,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
372,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
372,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,1,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
374,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
375,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
375,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
375,4,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
375,5,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
375,6,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
375,7,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
375,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
375,9,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,10,Decorticate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
375,11,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
375,12,Executive dysfunction,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
375,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
375,14,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
375,15,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
375,16,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
375,17,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
375,18,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
375,19,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
375,20,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
375,21,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
375,22,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
375,23,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
375,24,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
375,25,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
375,26,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
375,27,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
375,28,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
375,29,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
375,30,Partial seizures with secondary generalisation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
375,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
375,32,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
375,33,Reduced facial expression,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
375,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
375,35,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
375,36,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
375,37,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
375,38,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
376,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
376,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
376,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
376,4,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
376,5,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
376,6,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
376,7,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
376,8,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,N
376,9,Myocardial haemorrhage,Myocardial disorders NEC,Myocardial disorders,Card,N
376,10,Nephrosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
376,11,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
376,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
376,13,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
376,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
376,15,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
376,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
376,17,Visceral congestion,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
377,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
378,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
378,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
379,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
379,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
380,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
380,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
380,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
380,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
381,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
381,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
382,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
383,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
383,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
384,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
384,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
385,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
385,2,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
386,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
386,2,Neonatal hypoxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,Y
386,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
387,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
388,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
389,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
389,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
389,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
389,4,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
390,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
390,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
390,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
391,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
391,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
391,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
392,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
392,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
392,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
393,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
393,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
393,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
394,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
394,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
394,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
395,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
395,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
395,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
395,4,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
396,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
396,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
396,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
397,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
397,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
397,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
397,4,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
398,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
398,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
398,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
398,4,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
399,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
399,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
399,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
400,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
400,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
400,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
401,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
401,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
401,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
401,4,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
402,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
403,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
403,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
403,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
404,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
405,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
406,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
406,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
406,3,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
406,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
407,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
407,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
407,4,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
407,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
409,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
410,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
410,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
410,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
410,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
410,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
410,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
411,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
412,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
413,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
414,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
415,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
416,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
416,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
417,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
417,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
417,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
417,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
417,5,Stasis dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
418,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
418,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
419,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
419,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
420,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
420,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
420,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
421,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
421,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
421,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
422,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
422,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
422,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
423,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
423,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
424,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
424,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
425,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
425,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
425,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
426,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
426,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
427,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
427,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
428,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
428,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
428,4,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
429,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
429,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
429,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
430,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
431,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
431,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
431,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
431,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
431,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
432,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
432,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
432,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
432,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
432,5,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
432,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
432,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
432,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
433,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
434,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
435,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
436,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
437,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
438,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
439,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
440,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
440,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
440,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
440,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
440,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
440,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
441,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
441,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
442,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
442,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
443,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
444,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
445,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
446,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
446,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
446,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
446,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
446,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
447,1,Accidental death,Death and sudden death,Fatal outcomes,Genrl,N
447,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
448,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
448,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
449,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
449,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
450,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
451,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
451,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
451,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
451,5,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
451,6,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
451,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
451,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
452,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
452,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
452,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
452,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
452,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
453,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
453,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
453,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
453,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
454,1,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
455,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
456,1,Headache,Headaches NEC,Headaches,Nerv,N
456,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
456,3,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
458,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
459,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
459,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
459,3,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
459,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
460,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
461,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
463,2,Fatty liver alcoholic,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
463,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
463,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
465,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
465,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
466,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
467,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,1,Accidental death,Death and sudden death,Fatal outcomes,Genrl,Y
468,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
468,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
469,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
469,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
470,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
471,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
471,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
471,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
471,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
472,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
472,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
472,3,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
473,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
473,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
474,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
475,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
475,2,Pneumonitis aspiration,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
476,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
477,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
477,2,Burn infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
477,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
477,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
477,6,Joint instability,Joint related disorders NEC,Joint disorders,Musc,N
477,7,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
477,8,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
477,9,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
477,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,12,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
478,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
478,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
479,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
479,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
480,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
481,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
481,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
482,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
482,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
482,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
483,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
484,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
485,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
485,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
487,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
487,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
488,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
488,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
488,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
489,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
489,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
489,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
490,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
490,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
490,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
491,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
492,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
492,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
493,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
494,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
495,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
495,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
496,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
496,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
497,1,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
497,2,Stab wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
497,3,Traumatic liver injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
498,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
498,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
499,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
500,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
500,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
501,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
501,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
502,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
502,3,Poor weight gain neonatal,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
502,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
502,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
502,6,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
503,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
503,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
503,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
503,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
503,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
503,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
504,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
504,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
505,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
505,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
506,1,Pneumonitis aspiration,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
506,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
507,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
508,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
508,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
509,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
509,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
509,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
510,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
510,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
510,3,Malformation venous,Venous disorders congenital,Cardiac and vascular disorders congenital,Cong,N
511,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
511,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
511,3,Malformation venous,Venous disorders congenital,Cardiac and vascular disorders congenital,Cong,N
512,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
513,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
514,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
515,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
515,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
516,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
516,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
516,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
516,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
517,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
517,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
517,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
518,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
518,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
518,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
519,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
519,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
519,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
519,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
519,5,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
520,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
520,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
521,1,Counterfeit product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
521,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
521,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
521,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
521,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
521,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
521,7,Oxygen consumption decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
521,8,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
522,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
522,2,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
522,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
522,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
522,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
522,6,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
522,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
522,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
522,9,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
522,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
522,11,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
522,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
522,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
522,14,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
522,15,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
522,16,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
523,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
524,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
525,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
525,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
525,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
526,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
527,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
527,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
528,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
528,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
528,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
528,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
528,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
529,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
529,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
529,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
529,4,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
529,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
529,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
529,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
530,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
531,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
531,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
532,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,Y
532,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
533,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
533,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
534,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
535,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
535,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
535,3,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
535,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
535,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
536,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
536,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
536,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
536,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
536,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
536,6,Physical assault,Criminal activity,Legal issues,SocCi,N
536,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
536,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
537,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
538,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
539,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
539,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
539,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
540,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
540,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
540,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
540,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
540,6,Physical assault,Criminal activity,Legal issues,SocCi,N
540,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
540,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,1,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
541,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
542,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
543,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
544,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
545,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
546,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
546,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
546,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
547,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
548,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
548,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
548,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
548,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
548,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
549,1,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
549,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
550,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
550,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
550,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
551,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
551,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
551,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
552,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
552,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
552,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
553,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
553,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
553,3,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
553,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
554,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
554,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
554,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
554,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
555,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
555,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
555,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
555,4,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
556,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
557,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
557,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
557,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
557,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
558,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
558,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
559,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
559,2,Hanging,Death and sudden death,Fatal outcomes,Genrl,N
560,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
560,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
561,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
562,1,Alcoholism,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
562,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
563,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
563,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
563,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
563,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
563,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
563,6,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
563,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
563,8,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
563,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
563,10,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
564,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
565,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
565,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
565,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
565,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
565,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
565,6,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
565,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
565,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
565,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
566,2,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
566,3,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
566,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
566,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
567,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
567,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
568,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
568,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
569,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
570,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
570,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
570,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
570,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
571,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
572,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
572,2,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
573,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
573,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
574,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
574,2,Transient tachypnoea of the newborn,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
575,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
575,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
576,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
576,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
577,1,Congenital cerebrovascular anomaly,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
577,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
578,1,Congenital cerebrovascular anomaly,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
578,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
579,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
581,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
581,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
581,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
582,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
583,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
583,2,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
583,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
584,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
584,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
585,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
585,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,1,Left ventricular enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
586,2,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
587,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
587,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
588,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
588,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
588,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
589,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
589,2,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
589,3,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
589,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
589,5,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
589,6,Oropharyngeal plaque,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
589,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
589,8,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
589,9,Poor personal hygiene,Social issues NEC,Lifestyle issues,SocCi,N
589,10,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
589,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
590,1,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
590,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
590,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
591,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
591,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
591,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
591,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
591,5,Local anaesthetic systemic toxicity,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
591,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
591,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
591,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
592,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
592,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
592,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
592,4,Multiple drug therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,Y
593,1,Headache,Headaches NEC,Headaches,Nerv,N
593,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
593,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
593,4,Ureteral spasm,Ureteric disorders NEC,Ureteric disorders,Renal,N
594,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
595,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
595,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
596,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
597,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
597,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
598,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,2,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
599,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
599,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
600,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
601,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
601,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
602,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
602,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
602,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
602,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
602,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
602,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
602,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
602,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
603,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
604,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
605,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
605,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
606,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
606,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
606,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
606,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
607,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
607,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
607,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
607,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
607,6,Tooth restoration,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
608,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
608,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
609,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
609,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
609,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
609,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
609,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
609,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
610,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
610,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
611,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
612,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
612,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,3,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
613,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
613,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
614,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
614,2,Defect conduction intraventricular,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
615,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
615,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
615,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
615,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
616,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
617,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
617,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
617,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
618,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
618,2,Congenital nose malformation,Nasal disorders congenital,Respiratory disorders congenital,Cong,N
618,3,Constipation neonatal,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
618,4,Delayed visual maturation,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
618,5,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,6,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
618,7,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
618,8,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
618,9,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
618,10,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
618,11,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
618,12,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
618,13,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
618,14,Motor developmental delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
618,15,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
618,16,Renal hypoplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
618,17,Resistance to thyroid hormone,Thyroid disorders congenital,Endocrine disorders congenital,Cong,N
618,18,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
618,19,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
618,20,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
618,21,Tri-iodothyronine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
619,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
619,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
620,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
621,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
621,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
622,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
623,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
624,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
624,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
625,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
626,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
627,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
627,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
628,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
628,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
629,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
629,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
630,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
630,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
631,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
631,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
632,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
632,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
633,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
633,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
634,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
634,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
635,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
636,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
636,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
637,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
637,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
638,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
639,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
639,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
640,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
641,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
641,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
642,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
643,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
644,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
644,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
646,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
647,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
648,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
649,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
650,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
651,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
652,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
653,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
654,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
655,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
655,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
655,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
655,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
655,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
655,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
656,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
656,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
657,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
658,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
658,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
658,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
658,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
658,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
659,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
659,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
659,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
659,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
659,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
660,1,Drug detoxification,Drug withdrawal therapies,Therapeutic procedures and supportive care NEC,Surg,N
660,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
660,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
660,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
661,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
661,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
661,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
662,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
662,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
662,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
662,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
662,5,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
662,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
663,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
663,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
664,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
665,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
666,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
666,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
667,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
667,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
667,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
667,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
667,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
667,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
668,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
668,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
668,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
668,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
668,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
668,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
668,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
669,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
669,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
669,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
669,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
669,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
669,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
669,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
670,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
670,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
670,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
670,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
670,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
670,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
671,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
671,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
671,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
671,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
671,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
672,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
672,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
672,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
672,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
672,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
672,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
672,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
673,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
673,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
673,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
673,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
673,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
673,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
673,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
674,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
674,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
674,4,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
674,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
674,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
674,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
675,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
675,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
675,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
675,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
675,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
675,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
675,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
676,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
677,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
677,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
677,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
677,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
677,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
677,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
677,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
678,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
678,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
679,1,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
679,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
679,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
680,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
680,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
680,3,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,N
680,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
680,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
680,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
680,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
681,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
682,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
682,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
682,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
682,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
683,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
683,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
683,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
684,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
684,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
684,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
685,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
685,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
685,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
685,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
686,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
686,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
686,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
686,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
687,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
687,2,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
688,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
688,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
689,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
689,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
690,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
690,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
691,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
691,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
692,1,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
692,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
693,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
693,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
693,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
693,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
694,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
695,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
695,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
696,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
696,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
696,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
696,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
697,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,2,Drug-disease interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
698,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
698,2,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
698,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
699,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
700,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
700,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
700,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
700,4,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
701,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
702,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
702,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
702,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
702,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
702,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
702,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
702,7,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
702,8,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
702,9,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
702,10,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
702,11,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
702,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
702,13,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
702,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
703,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
703,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
703,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
703,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
703,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
703,6,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
703,7,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
703,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
703,9,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
703,10,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
703,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
703,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
704,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
704,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
704,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
704,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
704,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
704,6,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
704,7,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
704,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
704,9,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
704,10,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
704,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
704,12,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
704,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
705,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
705,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
705,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
705,5,Tracheobronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
705,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
705,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
706,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
706,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
707,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
707,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
707,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
708,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
709,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
709,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
709,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
709,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
710,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
710,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,N
711,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
711,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
711,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
711,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
712,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
712,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
713,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
713,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
714,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
714,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
715,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
716,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
716,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
717,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
717,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
717,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
718,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
718,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
718,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
718,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
719,1,Blood creatine phosphokinase,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
719,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
719,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
719,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
719,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
719,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
719,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
720,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
720,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
720,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
720,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
720,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
720,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
720,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
720,8,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
720,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
720,10,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
721,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
721,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
721,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
721,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
721,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
721,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
722,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
722,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
722,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
723,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
723,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
724,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
724,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
724,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
725,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
725,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
725,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
726,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
726,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
726,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
726,4,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
726,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
726,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
727,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
727,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
728,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
729,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
729,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
730,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
730,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
730,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
730,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
731,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
731,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
732,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
733,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
733,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
734,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
734,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
734,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
735,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
735,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
735,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
735,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
735,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
735,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
736,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
736,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
737,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
738,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
739,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
739,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
740,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
740,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
740,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
741,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
741,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
741,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
741,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
742,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
742,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
742,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
742,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
742,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
742,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
742,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
743,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
743,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
744,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
744,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
745,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
745,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
746,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
746,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
747,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
747,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
748,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
748,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
749,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
749,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
750,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
750,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
751,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
751,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
752,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
752,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
753,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
753,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
754,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
754,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
755,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
755,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
756,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
757,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
758,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
759,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
760,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
761,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
762,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
763,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
764,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
765,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
766,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
767,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
768,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
769,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
769,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
770,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
771,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
772,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
772,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
773,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
773,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
774,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
774,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
774,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
775,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
775,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
776,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
776,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
777,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
778,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
779,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
779,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
783,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
783,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
783,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
783,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
783,5,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
783,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
784,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
785,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
785,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
785,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
786,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
786,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
786,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
786,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
786,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
787,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
787,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
788,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
789,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
789,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
789,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
790,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
790,3,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
790,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
791,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,Y
791,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
791,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
791,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
791,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
792,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
793,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
794,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
795,1,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
795,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
795,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
795,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
796,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
796,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
796,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
797,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
797,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
797,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
797,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
797,5,Tracheobronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
797,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
798,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
798,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
798,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
798,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
798,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
798,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
799,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
799,2,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
799,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
799,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
800,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
801,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
801,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
802,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
803,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
803,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
804,1,Drug use disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
804,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
805,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
805,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
805,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
805,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
805,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
806,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
806,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
807,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
808,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
809,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
810,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
811,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
812,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
812,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
813,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
814,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
815,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
815,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
816,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
816,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
816,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
816,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
816,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
817,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
817,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
818,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
819,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
819,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
820,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
820,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
821,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
822,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
822,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
822,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
823,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
823,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
823,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
823,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
823,6,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
824,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
824,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
825,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
826,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
827,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
828,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
828,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
828,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
828,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
829,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
830,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
831,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
832,1,Drug clearance increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
832,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
833,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
